menu

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
Drug Info Rounds

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

close
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Comments
  • Overview

    FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.

    Released August 17, 2017

Facebook Comments

Recommended
Details
Comments
  • Overview

    FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.

    Released August 17, 2017

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 9/29/20